1. Home
  2. CCEL vs CNF Comparison

CCEL vs CNF Comparison

Compare CCEL & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • CNF
  • Stock Information
  • Founded
  • CCEL 1989
  • CNF 1999
  • Country
  • CCEL United States
  • CNF China
  • Employees
  • CCEL N/A
  • CNF N/A
  • Industry
  • CCEL Managed Health Care
  • CNF Finance: Consumer Services
  • Sector
  • CCEL Health Care
  • CNF Finance
  • Exchange
  • CCEL Nasdaq
  • CNF Nasdaq
  • Market Cap
  • CCEL 34.8M
  • CNF 35.7M
  • IPO Year
  • CCEL 1997
  • CNF 2018
  • Fundamental
  • Price
  • CCEL $4.20
  • CNF $4.89
  • Analyst Decision
  • CCEL Hold
  • CNF
  • Analyst Count
  • CCEL 1
  • CNF 0
  • Target Price
  • CCEL N/A
  • CNF N/A
  • AVG Volume (30 Days)
  • CCEL 5.1K
  • CNF 14.2K
  • Earning Date
  • CCEL 10-15-2025
  • CNF 08-28-2025
  • Dividend Yield
  • CCEL 15.26%
  • CNF N/A
  • EPS Growth
  • CCEL N/A
  • CNF N/A
  • EPS
  • CCEL N/A
  • CNF N/A
  • Revenue
  • CCEL $31,747,500.00
  • CNF $50,241,013.00
  • Revenue This Year
  • CCEL $0.30
  • CNF $252.34
  • Revenue Next Year
  • CCEL N/A
  • CNF N/A
  • P/E Ratio
  • CCEL N/A
  • CNF N/A
  • Revenue Growth
  • CCEL N/A
  • CNF N/A
  • 52 Week Low
  • CCEL $4.09
  • CNF $2.36
  • 52 Week High
  • CCEL $9.43
  • CNF $15.44
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 37.76
  • CNF 53.34
  • Support Level
  • CCEL $4.35
  • CNF $4.88
  • Resistance Level
  • CCEL $4.54
  • CNF $5.49
  • Average True Range (ATR)
  • CCEL 0.13
  • CNF 0.28
  • MACD
  • CCEL -0.02
  • CNF -0.04
  • Stochastic Oscillator
  • CCEL 0.00
  • CNF 47.64

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.

Share on Social Networks: